NMA: Nonprescription Medicines Academy

Recent Self Care News

  • No Additional Eye Health Benefit from Carotenoids, Omega-3 Fatty Acids

    In the recently concluded Age-Related Eye Disease Study 2 (AREDS2), adding lutein plus zeaxanthin or docosahexaenoic acid plus eicosapentaenoic acid to
    high daily doses of vitamins C and E, beta-carotene, zinc, and copper did not further reduce the risk of developing advanced age-related macular degeneration.

    May 29th, 2013

  • Parents Continue to Administer Nonprescription Cough and Cold Products to Young Children

    More than 40% of parents continue to administer nonprescription cough and cold medications to children younger than 4 years of age, according to the January 2013 University of Michigan C. S. Mott Children’s Hospital National Poll on Children’s Health. One in four parents reported giving decongestants to children younger than 4 years of age.

    May 29th, 2013

  • Anticholinergic Agents Cause Cognitive Impairment in Older Adults in As Little As Two Months

    The results of a 1-year retrospective cohort study conducted in primary care clinics in Indianapolis, Indiana, indicate that drugs with strong anticholinergic effects (e.g., diphenhydramine) cause cognitive impairment in older adults when taken continuously for as few as 60 days. Taking multiple drugs with weaker anticholinergic effects (e.g., cimetidine, ranitidine, loperamide) has a negative impact on cognition within 90 days.

    May 29th, 2013

  • Fish Oil Supplements Not Useful for Preventing Cardiovascular Disease or Death

    Daily treatment with omega−3 fatty acids derived from fish failed to reduce cardiovascular mortality and morbidity in the community-based Risk and Prevention Study in Italy.

    May 29th, 2013

  • Quick Takes

    • FDA allows labeling changes for nonprescription nicotine replacement therapy smoking cessation products
    • Family Health Care Flexibility Act seeks to restore OTC product eligibility for health savings account/flexible spending account reimbursement
    • Use of glucosamine supplements linked to increased intraocular pressure in patients with glaucoma
    • Study establishes vitamin D safe upper limit of 36 ng/mL
    • The Wall Street Journal column addresses use of valerian for insomnia
    • USA Today article discusses recent changes to sunscreen labels
    • Matrixx Initiatives to discontinue cold prevention claims for Zicam Cold Remedy
    • “Cinnamon Challenge” reviewed in journal Pediatrics
    • U.S. Preventive Services Task Force publishes recommendation statement on vitamin D and calcium supplementation to prevent fractures in adults
    • Perrigo chairman to analysts: $10 billion in branded pharmaceutical sales could make the Rx-to-OTC switch over the next 5 years

    May 29th, 2013

  • New Product Alerts

    • Allegra Intensive Relief/Cooling Relief Topical Products
    • Clearblue Advanced Digital Ovulation Test
    • Karbinal ER Extended-Release Oral Suspension (Rx only)

    May 29th, 2013

  • Patient Safety Alerts

    • All acetaminophen products on FDA Watch List
    • FDA targets dimethylamylamine supplements

    May 29th, 2013

  • Upcoming Health Observances

    • Men’s Health Month
    • National Immunization Awareness Month

    May 29th, 2013

  • USPSTF Recommends Against Low-Dose Vitamin D, Calcium for Primary Prevention of Fractures in Postmenopausal Women

    In a new recommendation statement on vitamin D and calcium supplementation to prevent fractures in adults, the U.S. Preventive Services Task Force (USPSTF) recommends against daily supplementation with 400 IU or less of vitamin D3 and 1,000 mg or less of calcium for the primary prevention of fractures in noninstitutionalized postmenopausal women.

    April 17th, 2013

  • New GERD Treatment Guidelines from American College of Gastroenterology

    The American College of Gastroenterology has released new treatment guidelines on the diagnosis and management of gastroesophageal reflux disease (GERD).

    April 17th, 2013